Intuitive buys IT startup for surgical video sharing, archiving, analysis

The acquisition of clinical video and image documentation company Orpheus Medical comes as big players like J&J and Medtronic are preparing to shake up the robotic surgery market. 

By Maria Rachal • Feb. 11, 2020

Qiagen, still independent, limps back from 2019

The Dutch maker of infectious disease instruments and consumables is seeking a rebound, with an early boost from coronavirus-driven demand. Cowen analysts noted the firm beat expectations but added: "The bar was quite low."

By Nick Paul Taylor • Feb. 5, 2020

Smith & Nephew acquires Tusker's PMA-winning ear infection device for ENT portfolio

The buyout of Tusker Medical comes two months after it won FDA premarket approval for an ear tube delivery system that can be used in young children with local anesthesia alone in a doctor's office.

By Maria Rachal • Jan. 24, 2020

Medical device sales flat, J&J CEO promises big year for robots

A Medical Device Business Review Day scheduled for this spring in New York City will feature "tangible evidence of not only the machines, but also the digital platform component," Alex Gorsky said of J&J's robotic surgery ventures.

By Nick Paul Taylor • Updated Jan. 23, 2020

Quest buys Helsinki-based Blueprint Genetics to expand reach

Blueprint Genetics sells 3,900 targeted single gene and more than 200 panel tests for conditions spanning 14 medical specialties. Financial terms of the all-cash equity deal were not disclosed.

By Rebecca Pifer • Jan. 22, 2020

Health IT to lead 2020 deals, KPMG predicts

The repeal of the medical device tax could boost investor interest in hot areas like non-invasive diagnostics, robotic surgery and AI-enabled devices, although health IT, pharma and biotech appear to be drawing more excitement.

By Linda Wilson • Jan. 15, 2020

LabCorp, Quest push for M&A-driven growth despite difficulties closing deals

“It’s still a very fragmented marketplace,” said Quest CEO Steve Rusckowski at JPM. "Trying to get people to move fast has been harder than I would have anticipated,” LabCorp's new CEO Adam Schechter told investors.

By Nick Paul Taylor • Jan. 15, 2020

RTI Surgical inks $490M deal to sell OEM unit to private equity

The divestiture will turn Michigan-based RTI into a pure play spine company with up to $200 million in cash, as private equity groups show growing interest in the medical technology sector.

By Nick Paul Taylor • Jan. 14, 2020

Medtronic buys new spinal cord tech to boost pain therapies unit

Amid a broader slowdown in the spinal cord stimulation market, Medtronic is acquiring technology from Stimgenics that offers a new way of programming its Intellis implant.

By Maria Rachal • Jan. 9, 2020

Digital health M&A flatlines in 2019, but IPO activity promising

Rock Health sees creation of remote patient monitoring reimbursement codes, progress on data blocking rules and FDA's Pre-Cert program as potential growth catalysts for the sector.

By Nick Paul Taylor • Jan. 8, 2020

OrthoPediatrics sells Vilex assets in preparation for more M&A

The device maker sold the adult piece of the Vilex business, which it acquired last year, for $25 million.

By Nick Paul Taylor • Jan. 7, 2020

Illumina scraps $1.2B PacBio takeover amid regulatory pushback

Cowen analysts listed Agilent, Danaher and Thermo Fisher as potential buyers of Pacific Biosciences.

By Nick Paul Taylor • Jan. 3, 2020

FTC slaps Stryker, Wright Medical with second request

In a second amendment to its tender offer statement for Wright Medical, Stryker acknowledged a Wright shareholder's class action lawsuit alleging Wright's solicitation statement was false and misleading.

By David Lim , Maria Rachal • Updated Jan. 23, 2020

Wright Medical filings, report hint of rivals to Stryker's $5.4B acquisition

Regulatory filings show as many as five parties besides Stryker, which agreed to pay $30.75 per share, were interested in bidding for Wright.

By Maria Rachal • Dec. 20, 2019

J&J takes over Verb Surgical as Verily exits robotics partnership

The move comes four years after J&J launched the venture with Google-backed Verily, further signaling the medtech giant's play for the digital surgery market after its $3.4 billion acquisition of Auris Health.

By Maria Rachal • Dec. 20, 2019

Delaware court deals blow to Boston Scientific in Channel Medsystems lawsuit

Boston Scientific's attempt to terminate its $275 million acquisition of cryoablation device maker Channel Medsystems was ruled inappropriate by the Delaware Court of Chancery Wednesday. 

By David Lim • Dec. 19, 2019

Fujifilm announces delay to $1.63B buyout of Hitachi's diagnostic imaging arm

Citing COVID-19's impacts as a source of slowdown, Fujifilm said the deal is no longer expected to close in July.

By Maria Rachal • Updated May 28, 2020

FTC seeks to block Illumina's $1.2B PacBio acquisition over monopoly concerns

Illumina announced Wednesday it will extend the end time of its merger plan with PacBio to March 31, 2020.

By David Lim • Updated Dec. 19, 2019

Medtronic acquires meal detection tech to bolster personalized closed loop system

Klue's fine motor artificial intelligence software that can sense eating will help future diabetes management systems become hands free, the company said.

By Maria Rachal • Dec. 18, 2019

The MedTech Dive Awards of 2019

From TAVR's takeoff to FDA's new approaches to premarket review, these are the industry forces that left their mark on medical technology this year.

Dec. 9, 2019

Baxter closes $350M acquisition of Sanofi's Seprafilm adhesion barrier

The company said it will immediately begin integrating the product, meant to reduce adhesion barriers in patients having abdominal or pelvic laparotomy procedures, into its advanced surgery business.

By Maria Rachal • Updated Feb. 18, 2020

Hologic unloads underperforming Cynosure medical aesthetics unit

"This divestiture was a long time coming and puts an end to a bad marriage," William Blair analyst Brian Weinstein said of Hologic's $1.6 billion deal in 2017. Now, the company expects $138 million in cash proceeds from its sale.

By Dana Elfin • Updated Dec. 30, 2019

Asian private equity group to buy Lumenis in $1B deal

The maker of minimally invasive devices used in aesthetic procedures competes with rivals like Candela Medical.

By Nick Paul Taylor • Nov. 20, 2019

Wright Medical growth slowed in run-up to Stryker deal

While Wright's Cartiva big toe treatment dragged on sales for a second straight quarter, Stryker expects the acquisition to bolster its broader extremities business, particularly in shoulder devices.

By Susan Kelly • Nov. 11, 2019

Exact Sciences closes Genomic Health deal, wins breakthrough tag for liver cancer blood test

The Cologuard maker said it intends to roll out the test for hepatocellular carcinoma in the second half of 2020.

By Maria Rachal • Nov. 8, 2019